There is no FDA-approved medication specifically designed to treat lymphedema. No pill or injection can replace the physical therapies that remain the gold standard for managing the condition. That said, several medications play important supporting roles, and research into drug treatments is more active than it has been in decades.
Why No Drug Has Been Approved Yet
Lymphedema happens when your lymphatic system can’t drain fluid properly, causing protein-rich fluid to build up in tissue. That buildup triggers inflammation, scarring, and further damage to lymphatic vessels over time. A 2021 systematic review in the Journal of Vascular Surgery confirmed that no pharmacologic therapy has been approved for lymphedema to date. The International Society of Lymphology’s 2023 consensus document echoes this, noting that “various pharmacologic treatment is on the horizon” but nothing has crossed the finish line.
The core challenge is that lymphedema involves mechanical failure of a drainage system. Drugs can target inflammation, infection, or fluid balance, but they can’t rebuild damaged lymphatic vessels or reroute fluid the way physical therapy and compression can.
The Current Standard: Physical Therapy, Not Pills
Complete decongestive therapy (CDT) remains the primary treatment. It combines manual lymphatic drainage (a specialized massage technique), compression bandaging or garments, exercise, and skin care. No medication is considered a substitute for CDT. Drugs that have been studied, including a class of plant-derived compounds called benzopyrones, are explicitly described by the International Society of Lymphology as “neither an alternative nor substitute” for CDT.
Why Diuretics Don’t Work for Lymphedema
This is one of the most common misconceptions. If the problem is excess fluid, a water pill should help, right? It doesn’t. Diuretics pull water out of tissues and into your bloodstream so your kidneys can remove it. But lymphedema fluid is thick with protein, and that protein-rich fluid can’t be easily mobilized into the vascular space. Taking diuretics may temporarily reduce swelling, but the proteins stay behind, drawing fluid right back in. Long-term diuretic use for lymphedema is discouraged because it offers marginal benefit while risking fluid and electrolyte imbalances.
The one exception: if you have a separate condition like heart failure or kidney disease that contributes to swelling alongside your lymphedema, diuretics may be appropriate for that specific problem. But they’re treating the other condition, not the lymphedema itself.
Antibiotics for Cellulitis Prevention
The medication most commonly prescribed to people with lymphedema isn’t for the swelling at all. It’s for preventing skin infections. Lymphedema significantly raises your risk of cellulitis, a bacterial skin infection that can spread rapidly and further damage lymphatic vessels. Each infection makes the lymphedema worse, creating a vicious cycle.
If you’ve had two or more episodes of cellulitis in a year, your doctor may recommend long-term preventive antibiotics. British Lymphology Society guidelines recommend penicillin V (250 mg twice daily) as the first choice, with the dose doubled if your BMI is 33 or higher. If you’re allergic to penicillin, doxycycline at 100 mg daily is the alternative, or clarithromycin at 250 mg daily if doxycycline isn’t tolerated either. These low-dose antibiotics are taken continuously, sometimes for years, to break the infection-inflammation cycle.
Preventing cellulitis is one of the most impactful things medication can do for lymphedema. Every infection episode causes additional scarring in lymphatic tissue, so stopping infections before they start protects whatever lymphatic function you still have.
Ketoprofen: The Most Promising Drug Candidate
Of all the medications being studied, ketoprofen has generated the most compelling early results. It’s an anti-inflammatory drug in the same family as ibuprofen, but its effects on lymphedema appear to be unique. Other anti-inflammatory drugs in the same class haven’t shown the same benefits.
In an open-label pilot study, ketoprofen treatment reduced skin thickness in lymphedema patients from an average of 62 mm to 27 mm. A follow-up placebo-controlled trial confirmed the effect: skin thickness dropped from about 49 mm to 41 mm in the ketoprofen group, while the placebo group saw no significant change. These studies were published in JCI Insight by researchers at Stanford.
The mechanism appears to involve a specific inflammatory pathway. Rather than working through the usual anti-inflammatory channels, ketoprofen blocks the production of a molecule called leukotriene B4, which drives inflammation and impairs lymphatic vessel growth. This pathway may explain why other common anti-inflammatory drugs don’t produce the same results. Ketoprofen also appears to promote the growth of new lymphatic vessels, something most drugs can’t do.
Despite these findings, ketoprofen is not yet approved or widely recommended for lymphedema. Long-term use of any anti-inflammatory in this class carries risks to the stomach, kidneys, and cardiovascular system. The International Society of Lymphology notes that anti-inflammatory drugs “may face drawbacks if administered long-term.” Larger trials are needed before ketoprofen could become a standard prescription.
Other Medications Under Investigation
Ubenimex, a drug already used in some countries for cancer treatment, was tested in a randomized trial at 450 mg daily for six months in patients with leg lymphedema. The trial has completed enrollment, but results have not yet established it as a proven option.
Selenium, an essential mineral, has shown some promise in small studies focused on breast cancer-related lymphedema. In one trial, patients who received selenium injections over two weeks saw meaningful improvements: 75% showed clinical improvement at the end of treatment, and at follow-up, over 83% had their lymphedema downgraded from a more severe stage to a less severe one. A separate study reported up to 25% reduction in edema volume. These are small studies, and selenium is not a standard treatment, but some clinicians incorporate it as a supplement.
Coumarin, a plant compound found in cinnamon and other plants, was studied for lymphedema starting in the 1970s and showed some ability to help break down proteins trapped in tissue. However, clinical studies revealed liver toxicity in some patients, and the compound was never approved for this use. It remains banned as a food additive in the United States.
What Actually Helps Right Now
If you’re looking for the “best medicine” for lymphedema, the honest answer is that the most effective treatments aren’t medications. Consistent use of compression garments, regular manual lymphatic drainage, exercise, and meticulous skin care do more to control lymphedema than any available drug. Preventive antibiotics protect against infections that would make things worse. And if early research on ketoprofen holds up in larger trials, the first true lymphedema drug could be on the horizon within the next several years.
For now, the most impactful thing you can do is work with a certified lymphedema therapist to build a daily management routine. The physical interventions aren’t glamorous, but they remain the only treatments with decades of evidence behind them.